{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:57:21Z","timestamp":1793314641087,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"DOI":"10.1007\/s43440-026-00846-6","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T05:43:06Z","timestamp":1773207786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CC8, a heterodimeric disintegrin from Cerastes cerastes snake venom, triggers apoptosis and restrains the dissemination of human glioblastoma cells"],"prefix":"10.1007","author":[{"given":"Maram","family":"Morjen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaoula","family":"Smati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrine","family":"Souissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar Ben","family":"Lamine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mbarka","family":"Barmet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie","family":"Chantome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Potier-Cartereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Vandier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najet","family":"Srairi-Abid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naziha","family":"Marrakchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jed","family":"Jebali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"issue":"8","key":"846_CR1","doi-asserted-by":"publisher","first-page":"7047","DOI":"10.3390\/ijms24087047","volume":"24","author":"JI Erices","year":"2023","unstructured":"Erices JI, Bizama C, Niechi I, et al. Glioblastoma microenvironment and invasiveness: new insights and therapeutic targets. Int J Mol Sci. 2023;24(8):7047. https:\/\/doi.org\/10.3390\/ijms24087047.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"846_CR2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/jmri.28743","volume":"58","author":"YW Park","year":"2023","unstructured":"Park YW, Vollmuth P, Foltyn-Dumitru M, et al. The 2021 WHO classification for gliomas and implications on Imaging diagnosis: part 1-key points of the fifth edition and summary of imaging findings on adult-type diffuse gliomas. J Magn Reson Imag. 2023;58(3):677\u201389. https:\/\/doi.org\/10.1002\/jmri.28743.","journal-title":"J Magn Reson Imag"},{"key":"846_CR3","doi-asserted-by":"publisher","first-page":"105780","DOI":"10.1016\/j.phrs.2021.105780","volume":"171","author":"W Wu","year":"2021","unstructured":"Wu W, Klockow JL, Zhang M, et al. Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance. Pharmacol Res. 2021;171:105780. https:\/\/doi.org\/10.1016\/j.phrs.2021.105780.","journal-title":"Pharmacol Res"},{"issue":"17","key":"846_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/CPAA.S497903","volume":"24","author":"Z Sarfraz","year":"2025","unstructured":"Sarfraz Z, Maharaj A, Venur VA, Lathia JD, Odia Y, Ahluwalia MS. Immunotherapy in glioblastoma: an overview of current status. Clin Pharmacol. 2025;24(17):185\u2013209. https:\/\/doi.org\/10.2147\/CPAA.S497903.","journal-title":"Clin Pharmacol"},{"issue":"2","key":"846_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1023\/a:1010689121904","volume":"52","author":"S Martin","year":"2001","unstructured":"Martin S, Toquet C, Oliver L, et al. Expression of bcl-2, bax, and bcl-xl in human gliomas: a re-appraisal. J Neurooncol. 2001;52(2):129\u201339. https:\/\/doi.org\/10.1023\/a:1010689121904.","journal-title":"J Neurooncol"},{"key":"846_CR6","doi-asserted-by":"publisher","unstructured":"Wang Q, Zhang L, Yuan X, et al. The relationship between the Bcl-2\/Bax proteins and the mitochondria-mediated apoptosis pathway in the differentiation of adipose-derived stromal cells into neurons. PLoS One. 2016;11:e0163327. https:\/\/doi.org\/10.1371\/journal.pone.0163327.","DOI":"10.1371\/journal.pone.0163327"},{"issue":"2\u20133","key":"846_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.bbamcr.2003.08.009","volume":"1644","author":"V Kirkin","year":"2004","unstructured":"Kirkin V, Joos S, Z\u00f6rnig M. The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta. 2004;1644(2\u20133):229\u201349. https:\/\/doi.org\/10.1016\/j.bbamcr.2003.08.009.","journal-title":"Biochim Biophys Acta"},{"key":"846_CR8","doi-asserted-by":"publisher","first-page":"985363","DOI":"10.3389\/fonc.2022.985363","volume":"12","author":"S Qian","year":"2022","unstructured":"Qian S, Wei Z, Yang W, Huang J, Yang Y, Wang J. The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Front Oncol. 2022;12:985363. https:\/\/doi.org\/10.3389\/fonc.2022.985363.","journal-title":"Front Oncol"},{"issue":"11","key":"846_CR9","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/ni.3545","volume":"17","author":"X Shen","year":"2016","unstructured":"Shen X, Burguillos MA, Osman AM, et al. Glioma-induced inhibition of caspase-3 in microglia promotes a tumor-supportive phenotype. Nat Immunol. 2016;17(11):1282\u201390. https:\/\/doi.org\/10.1038\/ni.3545.","journal-title":"Nat Immunol"},{"issue":"2","key":"846_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.canlet.2008.11.023","volume":"281","author":"S Fulda","year":"2009","unstructured":"Fulda S. Caspase-8 in cancer biology and therapy. Cancer Lett. 2009;281(2):128\u201333. https:\/\/doi.org\/10.1016\/j.canlet.2008.11.023.","journal-title":"Cancer Lett"},{"key":"846_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.brainres.2010.07.009","volume":"1352","author":"L Shi","year":"2010","unstructured":"Shi L, Chen J, Yang J, Pan T, Zhang S, Wang Z. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax\/Bcl-2 ratio and caspase-3 activity. Brain Res. 2010;1352:255\u201364. https:\/\/doi.org\/10.1016\/j.brainres.2010.07.009.","journal-title":"Brain Res"},{"key":"846_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.brainres.2012.06.047","volume":"1473","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Chen J, Chen L, et al. Low frequency and intensity ultrasound induces apoptosis of brain glioma in rats mediated by caspase-3, Bcl-2, and survivin. Brain Res. 2012;1473:25\u201334. https:\/\/doi.org\/10.1016\/j.brainres.2012.06.047.","journal-title":"Brain Res"},{"issue":"11","key":"846_CR13","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1111\/jphp.12619","volume":"68","author":"E Ska\u0142a","year":"2016","unstructured":"Ska\u0142a E, Sitarek P, Toma M, et al. Inhibition of human glioma cell proliferation by altered Bax\/Bcl-2-p53 expression and apoptosis induction by Rhaponticum carthamoides extracts from transformed and normal roots. J Pharm Pharmacol. 2016;68(11):1454\u201364. https:\/\/doi.org\/10.1111\/jphp.12619.","journal-title":"J Pharm Pharmacol"},{"issue":"5","key":"846_CR14","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1158\/0008-5472.CAN-05-2097","volume":"66","author":"F Manero","year":"2006","unstructured":"Manero F, Gautier F, Gallenne T, et al. The small organic compound HA14-1 prevents Bcl-2 interaction with Bax to sensitize malignant glioma cells to induction of cell death. Cancer Res. 2006;66(5):2757\u201364. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-2097.","journal-title":"Cancer Res"},{"issue":"4","key":"846_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/abbs\/gmq016","volume":"42","author":"J Huang","year":"2010","unstructured":"Huang J, Gao J, Lv X, et al. Target gene therapy of glioma: overexpression of BAX gene under the control of both tissue-specific promoter and hypoxia-inducible element. Acta Biochim. Biophys. Sin. (Shanghai). 2010;42(4):274\u201380. https:\/\/doi.org\/10.1093\/abbs\/gmq016.","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"846_CR16","doi-asserted-by":"publisher","first-page":"961933","DOI":"10.3389\/fimmu.2022.961933","volume":"13","author":"Y Zeng","year":"2022","unstructured":"Zeng Y, Cai Y, Chai P, et al. Optimization of cancer immunotherapy through pyroptosis: a pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma. Front. Immunol. 2022;13:961933. https:\/\/doi.org\/10.3389\/fimmu.2022.961933.","journal-title":"Front. Immunol"},{"key":"846_CR17","doi-asserted-by":"publisher","first-page":"738137","DOI":"10.1155\/2011\/738137","volume":"2011","author":"PH Vachon","year":"2011","unstructured":"Vachon PH. Integrin signaling, cell survival, and anoikis: distinctions, differences, and differentiation. J Signal Transduct. 2011;2011:738137. https:\/\/doi.org\/10.1155\/2011\/738137.","journal-title":"J Signal Transduct"},{"issue":"12","key":"846_CR18","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.cellbi.2006.06.022","volume":"30","author":"J Rajeswari","year":"2006","unstructured":"Rajeswari J, Pande G. Direct association between caspase 3 and alpha5beta1 integrin and its role during anoikis of rat fibroblasts. Cell Biol Int. 2006;30(12):963\u201369. https:\/\/doi.org\/10.1016\/j.cellbi.2006.06.022.","journal-title":"Cell Biol Int"},{"issue":"7","key":"846_CR19","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1172\/JCI14268","volume":"110","author":"S Kim","year":"2002","unstructured":"Kim S, Bakre M, Yin H, Varner JA. Inhibition of endothelial cell survival and angiogenesis by protein kinase a. J Clin Invest. 2002;110(7):933\u201341. https:\/\/doi.org\/10.1172\/JCI14268.","journal-title":"J. Clin. Invest"},{"issue":"4","key":"846_CR20","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/cdd.2015.131","volume":"23","author":"G Renner","year":"2016","unstructured":"Renner G, Janouskova H, Noulet F, et al. Integrin \u03b15\u03b21 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma. Cell Death Differ. 2016;23(4):640\u201353. https:\/\/doi.org\/10.1038\/cdd.2015.131.","journal-title":"Cell Death Differ"},{"key":"846_CR21","doi-asserted-by":"publisher","first-page":"113745","DOI":"10.1016\/j.biopha.2022.113745","volume":"155","author":"JR Chen","year":"2022","unstructured":"Chen JR, Zhao JT, Xie ZZ. Integrin-mediated cancer progression as a specific target in clinical therapy. Biomed Pharmacother. 2022;155:113745. https:\/\/doi.org\/10.1016\/j.biopha.2022.113745.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"846_CR22","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.toxicon.2005.02.024","volume":"45","author":"JJ Calvete","year":"2005","unstructured":"Calvete JJ, Marcinkiewicz C, Monle\u00f3n D, et al. Snake venom disintegrins: evolution of structure and function. Toxicon. 2005;45(8):1063\u201374. https:\/\/doi.org\/10.1016\/j.toxicon.2005.02.024.","journal-title":"Toxicon"},{"issue":"6","key":"846_CR23","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1021\/bi015627o","volume":"41","author":"JJ Calvete","year":"2002","unstructured":"Calvete JJ, Fox JW, Agelan A, Niewiarowski S, Marcinkiewicz C. The presence of the WGD motif in CC8 heterodimeric disintegrin increases its inhibitory effect on alphaIi(b)beta3, alpha(v)beta3, and alpha5beta1 integrins. Biochemistry. 2002;41(6):2014\u201321. https:\/\/doi.org\/10.1021\/bi015627o.","journal-title":"Biochemistry"},{"key":"846_CR24","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.ijbiomac.2016.02.008","volume":"86","author":"H Ben-Mabrouk","year":"2016","unstructured":"Ben-Mabrouk H, Zouari-Kessentini R, Montassar F, et al. CC5 and CC8, two homologous disintegrins from cerastes cerastes venom, inhibit in vitro and ex vivo angiogenesis. Int J Biol Macromol. 2016;86:670\u201380. https:\/\/doi.org\/10.1016\/j.ijbiomac.2016.02.008.","journal-title":"Int J Biol Macromol"},{"issue":"15","key":"846_CR25","doi-asserted-by":"publisher","first-page":"12427","DOI":"10.3390\/ijms241512427","volume":"24","author":"M Morjen","year":"2023","unstructured":"Morjen M, Zakraoui O, Abdelkafi-Koubaa Z, et al. CC5 and CC8, two disintegrin isoforms from cerastes cerastes snake venom decreased inflammation response in vitro and in vivo. Int J Mol Sci. 2023;24(15):12427. https:\/\/doi.org\/10.3390\/ijms241512427.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"846_CR26","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1006\/bbrc.1998.8536","volume":"246","author":"A Kadi","year":"1998","unstructured":"Kadi A, Pichard V, Lehmann M, et al. Effect of microtubule disruption on cell adhesion and spreading. Biochem Biophys Res Commun. 1998;246(3):690\u201395. https:\/\/doi.org\/10.1006\/bbrc.1998.8536.","journal-title":"Biochem Biophys Res Commun"},{"key":"846_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-1-61779-207-6_8","volume":"769","author":"J Marshall","year":"2011","unstructured":"Marshall J. Transwell(\u00ae) invasion assays. Methods Mol Biol. 2011;769:97\u2013110. https:\/\/doi.org\/10.1007\/978-1-61779-207-6_8.","journal-title":"Methods Mol Biol"},{"key":"846_CR28","doi-asserted-by":"publisher","unstructured":"Perazzoli G, Prados J, Ortiz R, et al. Temozolomide resistance in glioblastoma cell lines: implication of MGMT, MMR, P-glycoprotein and CD133 expression. PLoS One. 2015;10(10):e0140131. https:\/\/doi.org\/10.1371\/journal.pone.0140131.","DOI":"10.1371\/journal.pone.0140131"},{"issue":"1","key":"846_CR29","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1186\/s12885-021-08972-5","volume":"21","author":"MTC Poon","year":"2021","unstructured":"Poon MTC, Bruce M, Simpson JE, Hannan CJ, Brennan PM. Temozolomide sensitivity of malignant glioma cell lines - a systematic review assessing consistencies between in vitro studies. BMC Cancer. 2021;21(1):1240. https:\/\/doi.org\/10.1186\/s12885-021-08972-5.","journal-title":"BMC Cancer"},{"issue":"8","key":"846_CR30","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.procbio.2012.04.020","volume":"47","author":"R Thangam","year":"2012","unstructured":"Thangam R, Gunasekaran P, Kaveri K, Sridevi G, Sundarraj S, Paulpandi M, et al. A novel disintegrin protein from Naja naja venom induces cytotoxicity and apoptosis in human cancer cell lines in vitro. Process Biochem. 2012;47(8):1243\u201349. https:\/\/doi.org\/10.1016\/j.procbio.2012.04.020.","journal-title":"Process Biochem"},{"issue":"7","key":"846_CR31","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/toxins8070206","volume":"8","author":"MB Hammouda","year":"2016","unstructured":"Hammouda MB, Montenegro MF, S\u00e1nchez-Del-Campo L, et al. Lebein, a snake venom disintegrin, induces apoptosis in human melanoma cells. Toxins (Basel). 2016;8(7):206. https:\/\/doi.org\/10.3390\/toxins8070206.","journal-title":"Toxins (Basel)"},{"issue":"1","key":"846_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/mc.22470","volume":"56","author":"O Zakraoui","year":"2017","unstructured":"Zakraoui O, Marcinkiewicz C, Aloui Z, et al. Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor-induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expression. Mol Carcinog. 2017;56(1):18\u201335. https:\/\/doi.org\/10.1002\/mc.22470.","journal-title":"Mol Carcinog"},{"key":"846_CR33","doi-asserted-by":"publisher","unstructured":"Marinou I, Havaki S, Goutas N, et al. Action of the disintegrin contortrostatin on breast cancer cell primary cultures. Adv Breast Cancer Res. 2013;2:161\u201315\u201369. https:\/\/doi.org\/10.4236\/abcr.2013.24026.","DOI":"10.4236\/abcr.2013.24026"},{"issue":"10","key":"846_CR34","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1158\/1078-0432.CCR-04-2115","volume":"11","author":"TW Vogel","year":"2005","unstructured":"Vogel TW, Zhuang Z, Li J, et al. Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme. Clin Cancer Res. 2005;11(10):3624\u201332. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-2115.","journal-title":"Clin Cancer Res"},{"issue":"41","key":"846_CR35","doi-asserted-by":"publisher","first-page":"43452","DOI":"10.18632\/oncotarget.6171","volume":"6","author":"V Patil","year":"2015","unstructured":"Patil V, Pal J, Somasundaram K. Elucidating the cancer-specific genetic alteration spectrum of glioblastoma derived cell lines from whole exome and RNA sequencing. Oncotarget. 2015;6(41):43452\u201371. https:\/\/doi.org\/10.18632\/oncotarget.6171.","journal-title":"Oncotarget"},{"issue":"10","key":"846_CR36","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/toxins16100433","volume":"16","author":"Y Boughanmi","year":"2024","unstructured":"Boughanmi Y, Berenguer-Daiz\u00e9 C, Balzano M, et al. Antiproliferative effects of Naja anchietae and Naja senegalensis venom peptides on glioblastoma cell lines. Toxins (Basel). 2024;16(10):433. https:\/\/doi.org\/10.3390\/toxins16100433.","journal-title":"Toxins (Basel)"},{"issue":"19","key":"846_CR37","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.3390\/cancers15194805","volume":"15","author":"A Galicka","year":"2023","unstructured":"Galicka A, Szoka \u0141, Radziejewska I, Marcinkiewicz C. Effect of dimeric disintegrins isolated from vipera lebetina obtusa venom on glioblastoma cellular responses. Cancers (Basel). 2023;15(19):4805. https:\/\/doi.org\/10.3390\/cancers15194805.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"846_CR38","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1038\/s41598-019-38625-4","volume":"9","author":"M Alieva","year":"2019","unstructured":"Alieva M, Leidgens V, Riemenschneider MJ, Klein CA, Hau P, van Rheenen J. Intravital imaging of glioma border morphology reveals distinctive cellular dynamics and contribution to tumor cell invasion. Sci Rep. 2019;9(1):2054. https:\/\/doi.org\/10.1038\/s41598-019-38625-4.","journal-title":"Sci Rep"},{"issue":"49","key":"846_CR39","doi-asserted-by":"publisher","first-page":"86947","DOI":"10.18632\/oncotarget.20372","volume":"8","author":"L Malric","year":"2017","unstructured":"Malric L, Monferran S, Gilhodes J, et al. Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update. Oncotarget. 2017;8(49):86947\u201368. https:\/\/doi.org\/10.18632\/oncotarget.20372.","journal-title":"Oncotarget"},{"issue":"Pt3","key":"846_CR40","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1242\/jcs.071985","volume":"124","author":"CT Mierke","year":"2011","unstructured":"Mierke CT, Frey B, Fellner M, Herrmann M, Fabry B. Integrin \u03b15\u03b21 facilitates cancer cell invasion through enhanced contractile forces. J Cell Sci. 2011;124(Pt3):369\u201383. https:\/\/doi.org\/10.1242\/jcs.071985.","journal-title":"J Cell Sci"},{"issue":"5","key":"846_CR41","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3390\/pharmaceutics14051053","volume":"14","author":"W Echavidre","year":"2022","unstructured":"Echavidre W, Picco V, Faraggi M, Montemagno C. Integrin-\u03b1v\u03b23 as a therapeutic target in glioblastoma: back to the future? Pharmaceutics. 2022;14(5):1053. https:\/\/doi.org\/10.3390\/pharmaceutics14051053.","journal-title":"Pharmaceutics"},{"key":"846_CR42","doi-asserted-by":"publisher","unstructured":"Xu J, Shi P, Yang L, Cui H. Basic mechanism of mobilizing cell movement during invasion of glioblastoma and target selection of targeted therapy. J Adv Res. 2025;8:S2090\u20131232(25)00286\u20133. https:\/\/doi.org\/10.1016\/j.jare.2025.04.042.","DOI":"10.1016\/j.jare.2025.04.042"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00846-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-026-00846-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00846-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T05:43:08Z","timestamp":1773207788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-026-00846-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":42,"alternative-id":["846"],"URL":"https:\/\/doi.org\/10.1007\/s43440-026-00846-6","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}